Sangamo Therapeutics
SGMO
SGMO
152 hedge funds and large institutions have $137M invested in Sangamo Therapeutics in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
48% less call options, than puts
Call options by funds: $85K | Put options by funds: $162K
56% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 48
Holders
152
Holding in Top 10
–
Calls
$85K
Puts
$162K
Top Buyers
1 | +$4.43M | |
2 | +$3.06M | |
3 | +$1.64M | |
4 |
ECM
ExodusPoint Capital Management
New York
|
+$1.01M |
5 |
GC
Globeflex Capital
San Diego,
California
|
+$907K |
Top Sellers
1 | -$8.2M | |
2 | -$4.35M | |
3 | -$2.58M | |
4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.29M |
5 |
![]()
Rafferty Asset Management
New York
|
-$1.16M |